ArticleMolecular cancer2021

Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin.

Yuan Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.